Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
folic acid, Quantity: 5 mg/mL
Orthomolecular Medisearch Laboratories Pty Ltd Trading As Biological Therapies
Folic acid
Injection
Excipient Ingredients: water for injections; sodium hydroxide; disodium edetate
Intramuscular, Subcutaneous, Intravenous
10 x 1mL, 6 x 1mL, 1 x 1mL
(S4) Prescription Only Medicine
1. Megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. Prevention of folic acid deficiency in pregnancy and lactation.
Visual Identification: Yellow coloured, clear solution.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 12 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2006-01-19
BIOLOGICAL THERAPIES FOLIC ACID 5 MG IN 1 ML INJECTION _FOR INTRAMUSCULAR, SUBCUTANEOUS OR INTRAVENOUS INJECTION _ CONSUMER MEDICINE INFORMATION _Biological Therapies Folic Acid 5 mg in 1 mL Injection Version ID: NMcmi39s1907 _ _page 1 of 3 _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Biological Therapies Folic Acid Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of giving Folic Acid Injection against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BIOLOGICAL THERAPIES FOLIC ACID INJECTION IS USED FOR Folic Acid Injection contains the active ingredient folic acid; (2_S_)-2-[[4-[[(2- amino-4-oxo-1,4-dihydropteridin-6- yl)methyl]amino]benzoyl]amino] pentanedioic acid (a member of the Vitamin B group). Once administered, folic acid is converted to folate in the body. Folate Deficiency: Folic Acid Injection may be prescribed if you have a diagnosed folate deficiency and are unable to absorb sufficient folate through oral intake. Oral intake may be insufficient in; malabsorption disorders, alcoholism, gastrointestinal diseases, pregnancy and lactation, haemolytic anaemia, exfoliative dermatitis and chronic infection. For use in Pregnancy and Lactation: Without folate, cells cannot divide normally. This is especially important for all rapidly dividing cells in the body, such as the cells in a developing baby (foetus). Your doctor may prescribe Folic Acid Injection to prevent folate deficiency in pregnancy or lactation, particularly if you have a problem that decreases your folate levels. Megaloblastic Anaemia: Anaemia occurs when red blood cells cannot carry enough oxygen to meet the needs of the body’s cells. Folate is needed to make red blood cells grow properly, without it t Read the complete document
AUSTRALIAN PRODUCT INFORMATION BIOLOGICAL THERAPIES FOLIC ACID 5 MG IN 1 ML INJECTION FOR INTRAMUSCULAR, SUBCUTANEOUS OR INTRAVENOUS INJECTION Biological Therapies page 1 of 5 Product Information: FA5 - pi39s1901 AUST R 106972 1. NAME OF THE MEDICINE Folic acid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Biological Therapies Folic Acid Injection contains folic acid adjusted to pH with sodium hydroxide in water for injections. Disodium edetate 2 mg/mL is used as a stabiliser. Each 1 mL solution contains 5 mg of folic acid as an active ingredient. The total sodium content in undiluted Biological Therapies Folic Acid Injection 5 mg in 1 mL is approximately 1.0 mg/mL, the pH range 8 to 11. Folic acid, (2_S_)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino] benzoyl]amino]pentanedioic acid, is prepared synthetically. Folates are complex organic compounds present in liver, yeast and natural sources. For the full list of excipients, see Section 6.1 List of Excipients. 3. PHARMACEUTICAL FORM Biological Therapies Folic Acid Injection is a yellow colour and is a clear solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Folate deficiency may exist that is unable to be corrected by oral intake and in these cases parenteral administration may be preferable. Oral intake may be insufficient in: malabsorption disorders, gastrointestinal pathologies, pregnancy and lactation, alcoholism, haemolytic anaemia, exfoliative dermatitis and chronic infection. Specific indications may include: 1. Megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. Prevention of folic acid deficiency in pregnancy and lactation. 4.2 DOSE AND METHOD OF ADMINISTRATION Biological Therapies Folic Acid Injection is used for parenteral folic acid therapy, and may be administered, usually by intramuscular, or less commonly by intravenous or subcutaneous injection. Although Biological Therapies Folic Acid Injection can be given undiluted for intramuscular or subcutaneous use, it must be diluted befor Read the complete document